After Medicago shutdown, Canada recovers $40M and research on COVID-19 vaccine
Canada will see the recovery of $40 million owed in relation to the construction of Medicago's facility, and will see research and development assets transferred to Aramis.
Canada will see the recovery of $40 million owed in relation to the construction of Medicago's facility, and will see research and development assets transferred to Aramis.
